Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengzao Sun

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Angewandte Chemie (International Ed. in English)|March 3, 2005
Enzymatic incorporation of an antibody-activated blue fluorophore into DNAGunnar F Kaufmann, Michael M Meijler, Chengzao Sun, et al.
Journal of the American Chemical Society|October 17, 2002
Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigenKyung Joo Lee, Shenlan Mao, Chengzao Sun, et al.
Plos One|October 30, 2013
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybridsJames L Trevaskis, Christine M Mack, Chengzao Sun, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 13, 2021
Guiding Chemically Synthesized Peptide Drug Lead Optimization by Derisking Mast Cell Degranulation-Related Toxicities of a NaV1.7 Peptide InhibitorPierre Morissette, Nianyu Li, Jeanine E Ballard, et al.
Scientific Reports|July 30, 2024
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humansAnne M Fourie, Xiaoli Cheng, Leon Chang, et al.
Dermatology and Therapy|July 8, 2025
Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits SignalingBeverly Knight, Brinda Tammara, Nishit B Modi, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Angewandte Chemie (International Ed. in English)|March 3, 2005
Enzymatic incorporation of an antibody-activated blue fluorophore into DNAGunnar F Kaufmann, Michael M Meijler, Chengzao Sun, et al.
Journal of the American Chemical Society|October 17, 2002
Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigenKyung Joo Lee, Shenlan Mao, Chengzao Sun, et al.
Plos One|October 30, 2013
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybridsJames L Trevaskis, Christine M Mack, Chengzao Sun, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 13, 2021
Guiding Chemically Synthesized Peptide Drug Lead Optimization by Derisking Mast Cell Degranulation-Related Toxicities of a NaV1.7 Peptide InhibitorPierre Morissette, Nianyu Li, Jeanine E Ballard, et al.
Scientific Reports|July 30, 2024
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humansAnne M Fourie, Xiaoli Cheng, Leon Chang, et al.
Dermatology and Therapy|July 8, 2025
Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits SignalingBeverly Knight, Brinda Tammara, Nishit B Modi, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Pageof 3